Deleted in press. 328. Cannon CP, McCabe CH, Gibson CM, et al. TNK-tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95:351 6. 329. Martin GV, Sheehan FH, Stadius M, et al. Intravenous streptokinase for acute myocardial infarction: effects on global and regional systolic func- tion. Circulation. 1988;78:258 66. 330. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo- controlled trial. Lancet. 2005;366:1607 21. 331. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-seg- ment elevation. N Engl J Med. 2005;352:1179 89. 332. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfrac- tionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354:1477 88. 333. Efficacy and safety of tenecteplase in combination with enoxaparin, ab- ciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358:605 13. 334. Ross AM, Molhoek P, Lundergan C, et al. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation. 2001;104:648 52. 335. Antman EM, Louwerenburg HW, Baars HF, et al. Enoxaparin as adjunc- tive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002;105:1642 9. Erratum in: Circulation. 2002;105:2799. 336. Eisenberg PR. Role of heparin in coronary thrombolysis. Chest. 1992;101:131S 9S. 337. de Bono DP, Simoons ML, Tijssen J, et al. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind Euro- pean Cooperative Study Group trial. Br Heart J. 